PATENT CLAIM ANALYSIS

Application Number: 15522969
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-04
Patent Classification: ["514", "252030"]

Abstract:
Provided herein are compounds and methods for treating a disorder associated with aberrant A3 peptide levels, including Alzheimer's disease. Provided herein are compositions and methods for treating a disorder associated with aberrant Aβ peptide levels, including AD. Provided herein are compounds of Formula (A) or a pharmaceutically acceptable salt thereof, wherein, L′ is selected from the group consisting of C(O), C(R1)(R2), substituted or unsubstituted —C2-6 alkylene-, and substituted or unsubstituted —C3-6 cycloalkylene.

Claim (Index 2):
The compound of  claim 1  having the formula: or a pharmaceutically acceptable salt thereof, wherein, L 1  is C(O) or C(R 1 )(R 2 ); R 1  and R 2  are independently hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, or are optionally joined together to form a substituted or unsubstituted cycloalkyl; R 3  is hydrogen, halogen, \u2014CF 3 , \u2014CN, \u2014OR 3A , \u2014NR 3A R 3B , \u2014COOR 3A , \u2014CONR 3A R 3B , -substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 4  is hydrogen, halogen, \u2014CF 3 , \u2014CN, \u2014OR 4A , \u2014NR 4A R 4B , \u2014COOR 4A , \u2014CONR 4A R 4B , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 5  is independently hydrogen, halogen, \u2014CF 3 , \u2014CN, \u2014OR 5A , \u2014NR 5A R 5B , \u2014COOR 5A , \u2014CONR 5A R 5B , \u2014SR 5A , \u2014OCF 3 , \u2014OCHF 2 , substituted or unsubstituted alkyl, or substituted or unsubstituted heteroalkyl; R 6  and R 7  are independently substituted or unsubstituted C 1 -C 5  alkyl; R 3A , R 3B , R 4A , R 4B , R 5A , and R 5B  are independently hydrogen, \u2014OH, \u2014NH 2 , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or R 3A  and R 3B , R 4A  and R 4B , or R 5A  and R 5B  are independently optionally joined together to independently form a substituted or unsubstituted heterocycloalkyl, or substituted or unsubstituted heteroaryl; and z1 is an integer of 0, 1, 2, 3, 4, or 5.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 91.0
- Lexical Diversity: 1.77358
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15421258', '14775483', '14992396', '14550528', '13806692']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7842817623873922
- 35 USC 102 Novelty (BERT): 0.5451089361917267
- Combined Prediction Score: 0.7603644797678257
- Mean Citation Score: 364.897392
- Max Citation Score: 378.66806
- Similarity Product: 326.4908596997023

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test